The Medicines Patent Pool (MPP) is a not-for-profit organization founded in 2010 with the support of the United Nations. Its mission is to improve access to essential medicines in low and ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool, or MPP, have signed a new voluntary licensing ...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced an update to their voluntary licensing ...

The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start ...

ViiV Healthcare, a global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced an update to their voluntary licensing agreement with the Medicines Patent ...

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental COVID-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public ...

The relationship between intellectual property (IP) and access to the fruits of science has always been tumultuous. The unequal distribution of messenger RNA vaccines during the COVID-19 pandemic ...

May 18 (Reuters) - Roche and the Medicines Patent Pool have signed a licensing agreement to expand access to the Swiss drugmaker's flu drug, Xofluza, in low- and middle-income countries, the ...